[Use of cetamiphen and nicotinic acid in the treatment of patients with coronary atherosclerosis].
作者信息
Savenkov P M
出版信息
Kardiologiia. 1967 Apr;7(4):50-3.
PMID:5598475
Abstract
摘要
相似文献
1
[Use of cetamiphen and nicotinic acid in the treatment of patients with coronary atherosclerosis].[西他米芬与烟酸在冠状动脉粥样硬化患者治疗中的应用]
Kardiologiia. 1967 Apr;7(4):50-3.
2
[The effect of retabolyl on the lipid and protein metabolism of coronary atherosclerosis patients].[Retabolyl对冠状动脉粥样硬化患者脂质和蛋白质代谢的影响]
Kardiologiia. 1969 Jul;9(7):95-100.
3
[The use of cetamiphen in patients with coronary arteriosclerosis].[西他米芬在冠状动脉粥样硬化患者中的应用]
Sov Med. 1966 Apr;29(4):98-100.
4
[Use of atromide-S (chlorfibrate) for the treatment of patients with coronary arteriosclerosis].[使用安妥明-S（氯贝丁酯）治疗冠状动脉硬化患者]
Kardiologiia. 1969 Apr;9(4):73-7.
5
[Prolonged use of atromid in patients with coronary arteriosclerosis].
Kardiologiia. 1967 Oct;7(10):32-5.
6
7
8
9
The coronary drug project. Design, methods, and baseline results.
Circulation. 1973 Mar;47(3 Suppl):I1-50. doi: 10.1161/01.cir.47.3s1.i-1.
10
[Arteriosclerosis--nicotinic acid therapy. 7. Effect of nicotinic acid on lipoproteins].[动脉硬化——烟酸疗法。7. 烟酸对脂蛋白的影响]
Lakartidningen. 1971 Apr 7;68(15):1763-4.
Zotero 插件